An Investigator-Masked, Randomized, Parallel-Group Study of the Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis in Subjects With Dry Eye Disease
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2019
Price : $35 *
At a glance
- Drugs Voclosporin (Primary) ; Ciclosporin
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Aurinia Pharmaceuticals
- 22 Jan 2019 According to an Aurinia Pharmaceuticals media release, primary endpoint (Drop Discomfort Assessment Visual Analogue Scale(VAS) has not been met.
- 22 Jan 2019 According to an Aurinia Pharmaceuticals Media Release, Joseph Tauber, head of the renowned Tauber Eye Institute in Kansas city, is the principal investigator of the study.
- 22 Jan 2019 Results presented in an Aurinia Pharmaceuticals Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History